Welcome to our dedicated page for BOWHEAD SPECIALTY HLDGS SEC filings (Ticker: BOW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Bowhead Specialty Holdings Inc. (NYSE: BOW) SEC filings page brings together the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. As a specialty property and casualty insurance group, Bowhead Specialty uses its SEC reports to disclose underwriting performance, capital structure, governance matters and material agreements.
Investors can review annual reports on Form 10-K and quarterly reports on Form 10-Q for detailed information on gross written premiums by division, net earned premiums, loss and expense ratios, combined ratios, reinsurance arrangements and the composition of the investment portfolio. These filings also describe risk factors, capital management, reserves for losses and loss adjustment expenses, and other topics that are central to a specialty insurer’s financial profile.
Bowhead Specialty’s current reports on Form 8-K provide timely disclosure of specific events. Recent 8-K filings describe the completion of a public offering of 7.750% Senior Notes due 2030, the intended use of proceeds to fund capital contributions to an insurance subsidiary and other corporate purposes, the entry into a senior secured revolving credit facility, and the repayment and termination of a prior credit agreement. Other 8-Ks cover quarterly earnings press releases, investor presentations, secondary offerings of common stock by an existing stockholder, and changes to the board of directors and board committees.
On this page, users can also access S-3 shelf registration statements, prospectus supplements and related documents referenced in Bowhead Specialty’s capital markets transactions, as well as proxy materials and governance filings. Stock Titan enhances these filings with AI-powered summaries that explain key terms, highlight important covenants and capital metrics, and clarify how items such as senior notes, credit facilities and non-GAAP measures relate to the company’s overall financial position. Real-time updates from EDGAR help ensure that new Bowhead Specialty filings, including Forms 3, 4 and 5 for insider transactions when available, are quickly reflected for further analysis.
Bowhead Specialty Holdings Inc. is asking stockholders to vote at its 2026 virtual annual meeting on April 30, 2026. Investors will elect four Class II directors to terms ending in 2029 and ratify PricewaterhouseCoopers LLP as independent auditor for the 2026 fiscal year.
Stockholders of record as of March 3, 2026, when 32,838,035 common shares were outstanding, may vote online in advance or during the virtual meeting. The board is currently 11 members, with a majority deemed independent under NYSE rules, and uses staggered three-year terms.
The proxy describes director compensation, including a non-employee package anchored around $80,000 in cash and $80,000 in RSUs, and notes that the CEO, Stephen Sills, received 2025 total compensation of $4,309,280. It also details major holders, including GPC Fund at 27.3% and American Family Mutual Insurance Company at 15.3%, and outlines reinsurance and distribution arrangements with American Family affiliates.
Bowhead Specialty Holdings CEO Stephen J. Sills reported bona fide gifts of 255,400 shares of common stock on March 12–13. These G-code transactions reflect gift transfers from his direct holdings and several family trusts and GRATs. After these gifts, he holds 832,150 shares directly, along with multiple indirect trust and entity positions disclosed as of those dates.
Bowhead Specialty Holdings Inc. files its annual report describing a fast-growing specialty property and casualty insurer focused on complex commercial risks. Gross written premiums reached $862.8 million for the year ended December 31, 2025, up from $695.7 million in 2024 and $507.7 million in 2023.
The business is concentrated in Casualty lines, which generated $550.7 million of 2025 premiums, alongside Professional Liability, Healthcare Liability and the newer Baleen Specialty unit. Bowhead mainly writes excess and surplus lines through a craft model for large, complex risks and a digital model for smaller accounts.
The company relies on a strategic partnership with American Family Mutual Insurance Company, which issues policies and cedes 100% of business to Bowhead’s insurance subsidiary in exchange for a ceding fee. A conservative balance sheet, extensive reinsurance program, and investment-grade fixed income portfolio support its underwriting-first strategy and expansion across U.S. specialty markets.
Bowhead Specialty Holdings reported strong growth for the quarter and year ended December 31, 2025. Fourth-quarter gross written premiums rose 21.3% to $224.1 million, with net income of $14.8 million, or $0.44 per diluted share, and a combined ratio of 96.9%.
For full-year 2025, gross written premiums increased 24.0% to $862.8 million and net income grew 40.6% to $53.8 million, or $1.59 per diluted share. Adjusted net income was $55.6 million, or $1.65 per diluted share, with a 13.6% adjusted return on equity and a 96.5% combined ratio. Management highlighted rapid expansion of the Baleen digital platform and reiterated expectations for around 20% gross written premium growth in 2026, led by the Casualty division.
Bowhead Specialty Holdings Inc. CFO and Treasurer Brad Mulcahey reported equity compensation and related tax-withholding transactions in the company’s common stock.
On February 19, 2026, he acquired 25,145 shares through a grant of restricted stock units. On February 20, 2026, he disposed of 1,274 shares, surrendered to the issuer to cover required tax withholdings upon RSU vesting at $24.90 per share. Following these transactions, he directly owned 136,327 common shares.
Bowhead Specialty Holdings Inc. Chief Underwriting Officer David John Newman reported two equity-related transactions in common stock. On February 19, 2026, he acquired 23,488 shares at a stated price of $0.00 per share as a grant of restricted stock units. On February 20, 2026, he disposed of 1,443 shares at $24.90 per share, surrendering them back to the company to cover required tax withholdings upon vesting. After these transactions, he directly held just under 300,000 shares.
Bowhead Specialty Holdings Inc. CEO and President Stephen Jay Sills reported equity compensation grants and related tax withholding activity in Common Stock. On February 19, he received two stock awards totaling 90,703 and 88,566 shares, recorded as grant or award acquisitions at no cash cost.
On February 20, 5,419 shares were surrendered to the issuer to cover required tax withholdings due upon vesting of restricted stock units at $24.90 per share, a tax-withholding disposition rather than an open-market sale. He also reports additional indirect holdings through various family trusts and entities.
Bowhead Specialty Holdings Inc. Chief Accounting Officer Shirley Shek Li Yap reported two stock-based compensation entries involving the company’s common stock. On February 19, 2026, she acquired 9,826 shares through a grant of restricted stock units at a stated price of $0.0000 per share, as noted in a footnote explaining it reflects an RSU grant. On February 20, 2026, she disposed of 524 shares at $24.90 per share to satisfy required tax withholdings upon vesting of restricted stock units, with a footnote clarifying these shares were surrendered to the issuer for tax purposes rather than sold in the open market.
Bowhead Specialty Holdings Inc. received a Schedule 13G reporting that American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research beneficially own 1,827,525 shares of Bowhead common stock, representing 5.6% of the class as of December 31, 2025.
The filing shows sole voting power over 1,625,459 shares and sole dispositive power over 1,827,525 shares. The securities are reported as being held in the ordinary course of business, not for the purpose of changing or influencing control of Bowhead.
Bowhead Specialty Holdings Inc. director reported acquiring additional common stock in the company. On May 1, 2025, the reporting person acquired 4,038 shares of common stock at a stated price of $0, bringing their directly held beneficial ownership to 36,773 shares after the transaction.
The footnotes explain that this total includes 23,324 shares of common stock that were previously received on September 19, 2024 for no consideration, as part of a pro rata distribution connected to the dissolution of Bowhead Insurance Holdings LP. That earlier acquisition was treated as exempt from reporting under Rule 16a-9 of the Securities Exchange Act of 1934.